Introduction:
Allergic rhinitis is the most common atopic IgE mediated hypersensitivity disease of the nasal airway mucous membrane. It represents a global health problem affecting 18% to 40% of adults worldwide 1 . Antihistamines are the main stay of treatment and are recommended for all types of intermittent and persistent allergic rhinitis 2 . Compared with older antihistamines,newer antihistamines are shown to be more potent. One of these antihistamines is levocetrizine which is shown in many studies to be highly selective H1 antihistamine which has additional benefits of nasal decongestion, improving nasal airflow and is cost effective 3, 4 . Similar results have also been shown in case of another newer anti histamine-fexofenadine hydrochloride 5 . Hence, this study was done to compare both these drugs.
Materials and Methods:
For this study, 100 subjects who were aged between 12-65 years with moderate -severe symptoms of allergic rhinitis were chosen among outpatients attending Department of E.N.T, Kempegowda Institute of Medical Science, Bangalore. Patients who were willing to participate in the study were evaluated by means of proper history taking with help of a proforma, clinical examination and relevant laboratory investigations. Patients with three or more of following symptoms -sneezing, nasal obstruction, nasal discharge, itching of nose, itching of eyes, watering of eyes and palatal itching wereselected.Those patients with laboratory investigations showing absolute eosinophilic count more than 400 cells/ mm 3 , nasal smear study showing > 15% of eosinophils and with positive skin prick test for atleast one allergen were included in the study.
Patients were excluded from the study if they had any of the following-• Co-existing upper respiratory tract infection including sinusitis • Pregnant and lactating women • Co-existing systemic diseases • Use of oral/intranasal corticosteroids or antihistamines within one month of presentation to outpatient department
Baseline symptoms scores were recorded in the dairy from which were provided to them, explained about it and asked to maintain it throughout the study period of 4 weeks. Patients were sequentially randomized into two groupsGroup1 (50 patients) recievedlevocetrizine 5mgonce daily and Group2 (50 patients)received fexofenadine hydrochloride 120mg once daily for 4weeks. During 4 weeks treatment period, patients were evaluated at weekly intervals.
Results:
Mean age of patients in Group1 was 30.64 and Group2 was 34.72. Both the groups had statistically same mean age group with p=0.187. There were 18males and 32females in Group1 and 34males and 16females in Group2. Theduration of illness is statistically similar between the two groups (Group1-2.60+/-1.35 and Group2-2.08+/-1.04) with p=0.134. 26 patients (52%) had intermittent symptoms in Group1 compared to 24 patients (48%) in Group2 and24 patients (48%) had persistent symptoms in Group1 compared to 26 patients (52%) in Group2 and the distribution in the two groups were statistically similar with p=0.777. 6patients had family history of allergy in Group1 and 4patients in Group2.
Both treatment groups had comparable mean total symptoms scores at baseline indicating, similar severity of symp-
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toms among all patients at the start of study. There was 100% change of median symptoms score in Group1 compared to 91.67% in Group2 post treatment. Sneezing was present in all subjects included in the study in both groups.Levocetrizinewas effective in relieving sneezing in 36patients(76%) as compared to fexofenadine in 28patients (66%). Nasal obstruction was present in all the patients in both groups. 4 patients had persistent nasal obstruction in Group1 and 18 patients in Group2. 46patients(92%) in Group1 compared to 36patients(64%) in Group2 were relieved of nasal obstruction.
Nasal discharge was present in all the patients with relief of symptoms in96% of patients who were on levocetrizinetreatment compared to 48% on fexofenadine treatment. Nasal itching was present in 38 patients (67.9%) in Group I and in 48 patients (96%) in Group II. Fexofenadine was effective in relieving this symptom in all the patients compared to relief in 48 patients( 96%) on levocetrizine treatment.In other symptoms -itching of eyes, watering of eyes, palatal itching and itching of ears, both drugs are equally effective. Incidence of sedation was noted to be equal in both the groups (3.8%).
Total Symptoms score Table 3 -showing mean pattern of symptoms score.
Discussion:
Both levocetrizineand fexofenadine hydrochloride have been demonstrated to be effective in treating allergic rhinitis.In our study, the mean age of patients in both the groups was 30.64-34.72years.This may be attributed to the life style and activity in this age group, which is more compared to older age group, which will increase the chances of bringing them into contact with a wide variety of allergens.
Levocetrizinewas effective in relieving sneezing, nasal obstruction and nasal discharge in 76%, 92% and 96% of patients respectively compared to 66%, 64% and 48% of patients respectively on fexofenadine treatment. Nasal itching was present in 67.9% of patients in levocetrizinegroup and 96% of patients in fexofenadine group. All the patients were relieved of this symptom in fexofenadine group compared to 96%(48patients) in levocetrizinegroup. Though considerable reduction in severity of individual symptoms in each patients seen in both treatment group, the levocetrizinegroup had higher degree of reduction. Fexofenadine showed faster onset of action within minutes compared to levocetrizine which took around half an hour to an hour. But, the activity of levocetrizine lasted longer compared to fexofenadine. This goes in favour of studies done by Simons and Simons 6 , Michael Larbiget al 7 and Friedrich H et al 8 who have also noted the same results. Levocetrizine was effective in reducing nasal obstruction in 92% which goes in favour with other studies 3, 4 . As against the study conducted by David Bernstein et al 5 where fexofenadine was effective on nasal obstruction, this study showed not much effect in this symptom(64%). Popoyet al 9 and Wilson et al 10 found levocetrizine an effective tool not only for immediate short term allergic manifestation but also for long term symptomatic relief.Our study goes in favour with comparative studies done by Friedrich H et al Hence, we conclude that although both levocetrizine and fexofenadine are effective H1 receptor inverse agonists, levocetrizineis more effective than fexofenadine.
